EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women

Inês Martins1, Frank Louwen2, Diogo Ayres-de-Campos3

  • 1Department of Obstetrics and Gynecology, Santa Maria University Hospital, Lisbon, Portugal.

Insights

Pregnant women face higher risks from COVID-19. Vaccination is crucial for expectant mothers, especially those with high-risk pregnancies, to prevent severe illness and long-term health issues.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Maternal Health

Background:

  • The COVID-19 pandemic has caused widespread mortality and long-term health problems globally.
  • Pregnant women are identified as a vulnerable group with an elevated risk of severe illness following SARS-CoV-2 infection.

Purpose of the Study:

  • To highlight the increased risk of severe COVID-19 outcomes in pregnant individuals.
  • To emphasize the critical need for accessible vaccination programs for all pregnant women.

Main Methods:

  • This is a summary of existing research and public health data regarding COVID-19 in pregnancy.
  • Analysis of epidemiological trends and clinical outcomes associated with SARS-CoV-2 infection in pregnant populations.

Main Results:

  • Pregnant women with COVID-19 are at a significantly higher risk of severe disease progression and adverse outcomes.
  • Data indicates a clear benefit of vaccination in mitigating these risks.

Conclusions:

  • Urgent implementation of vaccination strategies for pregnant women is essential.
  • Health authorities and governments must prioritize offering COVID-19 vaccines to all pregnant individuals, particularly those with high-risk pregnancies.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
48.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
2.2K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
92